Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Jasper Therapeutics is a clinical-stage biotechnology company dedicated to advancing the field of hematopoietic cell transplantation. Their primary focus is on developing innovative conditioning agents, like their lead candidate JSP191 (briquilimab), an anti-CD117 monoclonal antibody, to create safer and more effective transplant procedures for patients with severe and life-threatening diseases, including autoimmune disorders, hematologic malignancies, and genetic diseases. The company aims to make curative cell therapies more accessible and successful for a broader range of patients.
Serves as the central hub for research and development, clinical operations, and corporate administration.
Modern laboratory and office facilities designed to support cutting-edge biomedical research and collaboration within a prominent biotech park.
A dynamic and mission-driven environment fostering innovation, collaboration, and a commitment to advancing patient care through scientific excellence. Employees are often passionate about making a tangible impact on patients' lives.
Strategically located in Redwood City, a key part of the San Francisco Bay Area's vibrant biotechnology cluster, providing access to talent, research institutions, and industry partners.
Jasper Therapeutics is primarily based in the United States, with its headquarters and core operations in California. The company conducts clinical trials for its therapeutic candidates which may involve sites in the U.S. and potentially expand to other international locations as its programs advance. Its global strategy focuses on developing therapies that can address patient needs worldwide.
2200 Bridge Pkwy, Suite #102
Redwood City
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Jasper Therapeutics' leadership includes:
Jasper Therapeutics has been backed by several prominent investors over the years, including:
In the past 12 months (approx. May 2023 - May 2024), Jasper Therapeutics saw significant leadership updates, including the appointment of a new CEO and COBO, and the transition of the former CEO to Chairman of the Board.
Discover the tools Jasper Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for companies like Jasper Therapeutics often use a combination of the employee's first name initial and last name, or first name and last name separated by a dot.
flast@jaspertherapeutics.com
Format
rpauli@jaspertherapeutics.com
Example
75%
Success rate
Jasper Therapeutics Investor Relations • May 9, 2024
Jasper Therapeutics announced its financial results for the first quarter ended March 31, 2024, and provided updates on its clinical programs, including JSP191 (briquilimab)....more
Jasper Therapeutics Investor Relations • April 2, 2024
The company reported the dosing of the first patient in its BEACON Phase 1b/2a clinical trial evaluating briquilimab as a targeted, non-toxic conditioning agent for allogeneic hematopoietic stem cell transplant in patients with CGD....more
Jasper Therapeutics Investor Relations • February 29, 2024
Jasper Therapeutics announced its participation in the Leerink Partners Global Biopharma Conference and the Oppenheimer Annual Healthcare Conference in March 2024....more
Jasper Therapeutics Investor Relations • October 2, 2023
Jasper announced key leadership appointments with Ronald Pauli, M.D. becoming CEO and Jeet Mahal becoming COBO. Bill Lis, former CEO, transitioned to Chairman of the Board....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Jasper Therapeutics, are just a search away.